Clinical and Ultrasonographic Evaluation of the Efficacy of Extracorporeal Shock Wave Therapy (ESWT) in Post-Stroke Spasticity

Recruiting N/A Interventional Study
Stroke Spastic Hemiplegia Extracorporal Shockwave Therapy (ESWT)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
35 – 65
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
32 (estimated)
Sponsor
Pamukkale University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This research evaluate the effectiveness of Extracorporeal Shock Wave Therapy (ESWT) for treating spasticity in the wrist flexor muscles (flexor carpi ulnaris - FCU and flexor carpi radialis - FCR) of chronic stroke patients. Spasticity, a common complication after a stroke, causes muscle stiffness, pain, and functional limitation, leading to increased healthcare costs and a lower quality of life…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age between 35 and 65 years. * First-ever stroke episode confirmed by MRI and/or CT scan. * Clinical diagnosis of hemiplegia. * More than 6 months post-stroke. * A Modified Ashworth Scale (MAS) score between 1 and 3 for wrist flexor spasticity. Exclusion Criteria: * History …
Contacts

Meltem Güneş Akıncı, Assistant professor

+905375145590

meltem_aytekin@hotmail.com

CONTACT